Partners' Directory

  Home   Search   Join the Partnership   Login

Contact General Specializations in Countries Contribution to the Global Plan Declaration

View this partner's profile

Organization Contact Information

Name: Global Alliance for TB Drug Development
Street 1: 40 Wall Street
Street 2: 24th Floor
City: New York
Province: NY
Post Code: 10005
Country: United States of America
Phone: 12122277540
Organization Email:
Web Site:
Other Online Presence:

Focal Point Contact Information

Salutation: Mr
First Name: Willo
Last Name: Brock
Title: Senior Vice President, External Affairs

Alternate Focal Point Contact Information

Salutation: Mr
First Name: Thomas
Last Name: Lynch
Title: Manager, Communications

General Information

Board Constituency: Developed Country NGO
Is your organization legally registered in your country: Yes
If yes, please enter your registration number:
Organization Type - Primary: Non-Governmental Organization
Organization Type - Secondary: Other Non-Governmental Organization (NGO)
Organization Description:
The TB Alliance is a not-for-profit, product development partnership accelerating the discovery and development of new TB regimens that will shorten treatment, be effective against susceptible and resistant strains, be compatible with antiretroviral therapies for those HIV-TB patients currently on such therapies, and improve treatment of latent infection. The TB Alliance is committed to ensuring that approved new drug regimens are affordable, widely adopted and available to those who need them.
Do you know about the UNHLM declaration:

Specializations / Areas of Work

Funding, including innovative and optimized approach to funding TB Care
Research and Development

Other Organization Information

Total number of staff in your organization: 26 - 50
Number of full-time staff who are directly involved with TB: 26 - 50
Number of part-time staff who are directly involved with TB: 0
Number of volunteers who are directly involved with TB: 0
How did you hear about the Stop TB Partnership: Attendance at a TB related event
If you were informed or referred by another partner of the Stop TB Partnership please tell us who:
Why do you wish join the Stop TB Partnership: Other (please explain)
Are you a member of a Stop TB national partnership: United States of America
Are you in contact with your national TB programme: Yes
Please tell us how your organization is contributing to your country's national TB control plan:
Development of new tools for TB is a critical component of the Stop TB Strategy as well as the plan for the elimination of TB in the country our organization is located in.

Geographical Reach

Which country is your headquarters located in: United States of America
Which countries do you do operate in:
(This includes countries you are conducting activities in)
South Africa
United Kingdom of Great Britain and Northern Ireland
United Republic of Tanzania
United States of America


Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below:

Drug-Resistant TB:
Development of new TB regimens that will improve the treatment of drug-resistant TB by shortening therapy and making it more affordable. Advocacy efforts to support the development of improved diagnostics.

Development of new TB regimens that are ARV-compatible.

Laboratory Strengthening:
Capacity building through research and development work

New TB Drugs:
Development of new TB regimens


Declaration of interests:
No conflicts of interest were delacred.

Application date:  
Last updated: July 27, 2017